These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


941 related items for PubMed ID: 9725233

  • 1. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 2. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1996 Jan 15; 215(2):113-23. PubMed ID: 8560758
    [Abstract] [Full Text] [Related]

  • 3. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
    Ross SR, Dzuris JL, Golovkina TV, Clemmons WC, van den Hoogen B.
    Medicina (B Aires); 1997 Jan 15; 57 Suppl 2():34-42. PubMed ID: 9567342
    [Abstract] [Full Text] [Related]

  • 4. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1997 Sep 15; 236(1):54-65. PubMed ID: 9299617
    [Abstract] [Full Text] [Related]

  • 5. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 6. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 7. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 8. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 15; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 9. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R, Wang H, Bluethmann H, Iglesias A, Wei WZ.
    Cancer Res; 1994 Mar 15; 54(6):1529-35. PubMed ID: 8137259
    [Abstract] [Full Text] [Related]

  • 10. Retrovirus-host interactions. The mouse mammary tumor virus model.
    Acha-Orbea H.
    Medicina (B Aires); 1997 Mar 15; 57 Suppl 2():43-52. PubMed ID: 9567343
    [Abstract] [Full Text] [Related]

  • 11. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 12. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May 15; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

  • 13. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
    Bhadra S, Lozano MM, Dudley JP.
    J Virol; 2009 Jan 15; 83(1):484-8. PubMed ID: 18922863
    [Abstract] [Full Text] [Related]

  • 14. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, Acha-Orbea H.
    Eur J Immunol; 1994 Aug 15; 24(8):1757-64. PubMed ID: 8056034
    [Abstract] [Full Text] [Related]

  • 15. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA, Maillard I, Luthi F, Scarpellino L, Diggelmann H, Acha-Orbea H.
    J Immunol; 1997 Sep 15; 159(6):2807-14. PubMed ID: 9300703
    [Abstract] [Full Text] [Related]

  • 16. A novel mechanism of resistance to mouse mammary tumor virus infection.
    Golovkina TV.
    J Virol; 2000 Mar 15; 74(6):2752-9. PubMed ID: 10684291
    [Abstract] [Full Text] [Related]

  • 17. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E, Scarpellino L, Lane P, Acha-Orbea H.
    Eur J Immunol; 1996 Jul 15; 26(7):1595-602. PubMed ID: 8766566
    [Abstract] [Full Text] [Related]

  • 18. Massive mammary gland infection and pregnancy-dependent mammary tumor development in mice infected neonatally with mouse mammary tumor virus (SW) but not in mice infected as adults, despite a dramatic local response.
    Papiernik M, Waché AC, Pontoux C, Nabarra B.
    Eur J Immunol; 1997 Sep 15; 27(9):2145-51. PubMed ID: 9341752
    [Abstract] [Full Text] [Related]

  • 19. [Superantigens and murine mammary tumor retrovirus].
    Piazzon I, Nepomnaschy I, Buggiano V, Bekinschtein P, Goldman A, Berguer P, Deroche A, Lombardi G.
    Medicina (B Aires); 1997 Sep 15; 57 Suppl 2():21-33. PubMed ID: 9567341
    [Abstract] [Full Text] [Related]

  • 20. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ, Lozano M, Binhazim AA, Dudley JP.
    J Virol; 1998 Jun 15; 72(6):4746-55. PubMed ID: 9573239
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.